MA35868B1 - Mise en correspondance de débits - Google Patents

Mise en correspondance de débits

Info

Publication number
MA35868B1
MA35868B1 MA37215A MA37215A MA35868B1 MA 35868 B1 MA35868 B1 MA 35868B1 MA 37215 A MA37215 A MA 37215A MA 37215 A MA37215 A MA 37215A MA 35868 B1 MA35868 B1 MA 35868B1
Authority
MA
Morocco
Prior art keywords
flow mapping
bits
transmission
rate matching
matching device
Prior art date
Application number
MA37215A
Other languages
English (en)
French (fr)
Inventor
Pasi Eino Tapio Kinnunen
Kari Juhani Hooli
Original Assignee
Nokia Solutions & Networks Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46963763&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA35868(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/070550 external-priority patent/WO2014060028A1/en
Application filed by Nokia Solutions & Networks Oy filed Critical Nokia Solutions & Networks Oy
Publication of MA35868B1 publication Critical patent/MA35868B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Communication Control (AREA)
MA37215A 2012-01-24 2014-07-15 Mise en correspondance de débits MA35868B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201230092A ES2416004B1 (es) 2012-01-24 2012-01-24 Composición farmacéutica que comprende cloruro de isometamidium en solución para el tratamiento de la tripanosomiasis en animales.
PCT/EP2012/070550 WO2014060028A1 (en) 2012-10-17 2012-10-17 Rate matching

Publications (1)

Publication Number Publication Date
MA35868B1 true MA35868B1 (fr) 2014-12-01

Family

ID=46963763

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37215A MA35868B1 (fr) 2012-01-24 2014-07-15 Mise en correspondance de débits

Country Status (16)

Country Link
AP (1) AP2014007798A0 (es)
AR (1) AR089037A1 (es)
BR (1) BR112014016926A8 (es)
CL (1) CL2014001780A1 (es)
CO (1) CO6990714A2 (es)
CR (1) CR20140278A (es)
DO (1) DOP2014000161A (es)
EC (1) ECSP14010152A (es)
ES (1) ES2416004B1 (es)
GT (1) GT201400159A (es)
MA (1) MA35868B1 (es)
MX (1) MX2014008172A (es)
NI (1) NI201400075A (es)
PE (1) PE20141472A1 (es)
UY (1) UY34479A (es)
WO (1) WO2013110830A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024008B (en) * 1978-06-28 1983-02-16 Merck & Co Inc Compositions for treating trypanosomiasis infections
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
US5496830A (en) * 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
DE19854143A1 (de) * 1998-11-24 2000-05-25 Chambord Ltd Pharmazeutisches Präparat mit trypanozider und blutschizontozider Wirkung
FR2819188B1 (fr) * 2001-01-08 2003-03-14 Virbac Sa Compositions pulverulentes ou granulees hydrosolubles, a base de phenanthridines et leurs utilisations
AR060926A1 (es) * 2007-05-14 2008-07-23 Ciriaco Quiroga Solucion anestesica transparente de propofol, con baja irritacion venosa.
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
DE102008007381A1 (de) * 2008-02-01 2009-08-13 Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten
WO2011042565A2 (en) * 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Also Published As

Publication number Publication date
CL2014001780A1 (es) 2014-10-24
ECSP14010152A (es) 2015-08-31
ES2416004B1 (es) 2014-01-28
MX2014008172A (es) 2014-10-06
AR089037A1 (es) 2014-07-23
ES2416004A1 (es) 2013-07-29
CO6990714A2 (es) 2014-07-10
AP2014007798A0 (en) 2014-07-31
BR112014016926A2 (pt) 2017-06-13
WO2013110830A1 (es) 2013-08-01
PE20141472A1 (es) 2014-11-05
NI201400075A (es) 2015-04-13
GT201400159A (es) 2015-11-19
UY34479A (es) 2013-07-31
CR20140278A (es) 2014-12-02
DOP2014000161A (es) 2014-08-15
BR112014016926A8 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
MX368975B (es) Sistema de medición de flujo ultrasónico y método para medir velocidad de flujo.
MY186653A (en) Fluid inflow
SA516371696B1 (ar) طريقة لتفسير بيانات مستشعرات درجة الحرارة الموزعة خلال عمليات حفرة البئر
FR3021519B1 (fr) Dispositif de visualisation de l'interieur d'une bouche d'un patient.
MX2012014772A (es) Aparato y metodo para contener petroleo a partir de un pozo de petroleo en agua profunda.
GB2538439A (en) Submersible pump monitoring
MX358599B (es) Determinar la composición del fluido de tratamiento con un dispositivo de miniyacimiento.
SA516380304B1 (ar) أنظمة وطرق لتحديد متغير انسيابية
GB2536141A (en) Method and system for monitoring fluid flow in a conduit
MX2016001188A (es) Estimacion y prediccion de tortuosidad de pozo.
MY185589A (en) System and method for determining drill string motions using acceleration data
MX2018002536A (es) Medicion de propiedades del cemento.
MX2017007582A (es) Metodo ultrasonico y dispositivo para medir flujo de fluido.
FR3018580B1 (fr) Bloc robinet pour recipient de gaz avec dispositif indicateur de pression ou d’autonomie en position haute
GB2540288A (en) System and method for analyzing wellbore survey data to determine tortuosity of the wellbore using displacements of the wellbore path from reference lines
EA201590465A1 (ru) Способ и устройство получения данных скважины в режиме реального времени
GB2505134A (en) Fluid flow measurement sensor method and analysis
MX365729B (es) Metodos y sistemas de muestreo para el fluido de formacion.
MX357894B (es) Sistema de desviador marino con deteccion de perdida o rebote en tiempo real.
GB2536529A (en) Drilling fluid flow measurement in an open channel fluid conduit
TW201613526A (en) Apparatus, computer program product and computer readable medium using audio signal for detection and determination of narrowing condition of fluid pipe
FR3022577B1 (fr) Dispositif de chemisage ou d'obturation d'un puits ou d'une canalisation
MX2017004154A (es) Estimacion de retiro de recortes.
MA35868B1 (fr) Mise en correspondance de débits
TW201612547A (en) Method and apparatus for power saving in global navigation satellite system (GNSS) receivers